esmolol has been researched along with Brain Neoplasms in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Badri, AM; Bebawy, JF; Carabini, LM; Gupta, DK; Hemmer, LB; Houston, CC; Koht, A; Kosky, JL; Moreland, NC | 1 |
Auquier, P; Bruder, N; Gouin, F; Grillo, P; Pellissier, D | 1 |
2 trial(s) available for esmolol and Brain Neoplasms
Article | Year |
---|---|
Nicardipine is superior to esmolol for the management of postcraniotomy emergence hypertension: a randomized open-label study.
Topics: Aged; Anesthesia Recovery Period; Antihypertensive Agents; Brain Neoplasms; Craniotomy; Female; Humans; Hypertension; Male; Middle Aged; Nicardipine; Postoperative Complications; Propanolamines | 2015 |
Esmolol blunts the cerebral blood flow velocity increase during emergence from anesthesia in neurosurgical patients.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Anesthesia Recovery Period; Arteriovenous Fistula; Blood Flow Velocity; Blood Pressure; Brain Neoplasms; Cardiac Output; Cerebrovascular Circulation; Double-Blind Method; Female; Heart Rate; Humans; Intracranial Aneurysm; Male; Middle Aged; Middle Cerebral Artery; Neurosurgical Procedures; Propanolamines | 2003 |